Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ZiO-Zdorovye is a prominent Russian pharmaceutical manufacturer based in Podolsk, specializing in the production of high-quality finished dosage forms. Established in 2001, the company operates a state-of-the-art facility designed and built in strict accordance with international Good Manufacturing Practice (GMP) standards. It provides a comprehensive range of services including the production of tablets, hard gelatin capsules, and powders in sachets for both its own generic portfolio and as a contract manufacturer for international partners. As a subsidiary of the Pharmstandard group, ZiO-Zdorovye plays a vital role in the Russian healthcare system by ensuring the supply of essential medicines across various therapeutic areas such as gastroenterology and cardiology. The company is recognized for its advanced quality control laboratories and its ability to handle complex pharmaceutical formulations at scale.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZiO Zdorovye.